Ledger.Open graph →
SEC Form D · filed May 16, 2018

Processa Pharmaceuticals, Inc

Offering
$8.0M
Sold
$2.5M
Exemption
Rule 506(c)
Industry
Pharmaceuticals
Location
HANOVER, MD
Type

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (20)

Justin W. Yorke · Hanover, MDDirectorSian W. Bigora · Hanover, MDExecPatrick Lin · Hanover, MDExec · DirectorVirgil W. Thompson · Hanover, MDDirectorDavid Young · Hanover, MDExec · DirectorWendy W. Guy · Hanover, MDExecDerek A. Reisfield · Sunnyvale, CADirectorEagle Point Global Management GP, LLC · Seattle, WADirectorMark F. Van Coeverden De Groot · Toronto, Ontario, CanadaExec · DirectorEagle Point Global Management, LP · Seattle, WAExec · DirectorRichard A. Cohen · Sunnyvale, CAExecAnthony M. Leach · San Francisco, CAExecHelen W. Pentikis · Hanover, MDExecBrian Cassidy · New York, NYExec · DirectorStephen Tiller · New York, NYDirectorGregory J. Smith · New York, NYExec · DirectorClifford T. Bengis · Seattle, WAExecJaetaek J. Yang · Seattle, WADirectorStephanie Whalen · Silver Spring, MDExecHelen W. Pentikis · Hanover, MDExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗